Kenneth Melby
Pulmonary Disease · Decatur, GANPI 1033299144
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,513 and has fallen 98.3% since, to $25 in 2022. That places this record below the midpoint for pulmonary disease clinicians in GA, where the typical reported total is $3,789.
Across 118 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$378
- GSK$294
- AstraZeneca$272
- Actelion Pharmaceuticals US, Inc.$127
- Regeneron Healthcare Solutions, Inc.$107
- Grifols USA, LLC$97
- plus $615 from 18 others
What the payments were for
- Food & beverage$1,889100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 19 | $378 |
| GSK | 27 | $294 |
| AstraZeneca | 17 | $272 |
| Actelion Pharmaceuticals US, Inc. | 7 | $127 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| Grifols USA, LLC | 7 | $97 |
| Sunovion Pharmaceuticals Inc. | 7 | $94 |
| Mallinckrodt Enterprises LLC | 3 | $67 |
| Mylan Specialty L.p. | 4 | $63 |
| Johnson & Johnson | 3 | $57 |
| Genentech USA, Inc. | 3 | $42 |
| Sanofi | 2 | $41 |
| United Therapeutics Corporation | 2 | $35 |
| Novartis | 2 | $32 |
| Vapotherm Inc | 1 | $25 |
| Inogen, Inc. | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Shire North American Group Inc | 1 | $20 |
| Advanced Respiratory, Inc | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Circassia Inc. | 1 | $16 |
| AbbVie | 1 | $14 |
| Insmed, Inc. | 1 | $14 |
How this compares
$1,889 in reported general payments places this provider in the 35th percentile of 365 pulmonary disease providers in Georgia.
Other pulmonary disease in Decatur
- David MillerDecatur$206K
- Thomas DemariniDecatur$59K
- Jose AristizabalDecatur$18K
- Chuansheng WuDecatur$17K
- Harold JacksonDecatur$15K
- Lawrence McDermottSavannah$963K
- Vivek SambharaGainesville$417K
- Chad MillerAustell$382K
- Nehal BhattAthens$371K
- Maria MascoloRincon$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.